Imetelstat: a first-in-class telomerase inhibitor

A unique molecule targeting a hallmark of cancer

August 2017 corporate presentation

Download the latest company presentation

A transformative approach

Disease-modifying potential in hematologic malignancies

Together we can make a difference in patients’ lives

Partnerships are key to our success

A visionary history

Creating a legacy of bold innovation